Using different cutoff values, CLDN18.2-expressing tumor cells with 2+/3+ staining intensity in ≥40% and ≥25% of tumor cells were present in 70.6% and 73.5% of resected specimens, respectively (Fig 3C). This evidence concerns the gene CLDN18 and neoplasm.